Encorate Inj

ENCORATE INJ by SUN PHARMA-SYNERGY DIV

Name:

• Common Name: Sodium Valproate Injection
• Brand Name: ENCORATE INJ (by SUN PHARMA-SYNERGY DIV)

Composition: ENCORATE INJ contains Sodium Valproate as its active ingredient, typically at a concentration of 100 mg/ml.

Uses: ENCORATE INJ is an anticonvulsant or anti-epileptic medication primarily used to treat severe epileptic seizures/fits, especially when oral medications are not feasible. It stabilizes electrical activity in the brain, reducing the frequency and severity of seizures. Additionally, it is prescribed for:

• Bipolar disorder (to treat manic episodes and stabilize mood)
• Migraine prophylaxis (prevention of migraine headaches)
• Prevention of seizures during or after severe head injury and/or neurosurgery

Dosage and Administration: ENCORATE INJ is administered intravenously by a healthcare professional; it should not be self-administered. The dosage and frequency depend on the patient's age, health, weight, and response to treatment. For initiation, a typical starting dose is 10 mg/kg (usually 400-800 mg) given as a slow intravenous injection over 3-5 minutes, followed by continuous or repeated infusion up to a maximum of 2500 mg per 24 hours. The daily dose should be divided into at least two doses. For ongoing treatment, the intravenous dose may match the previously administered oral dose.

Side Effects: Common side effects include:

• Sleepiness, dizziness, tiredness, weakness, asthenia
• Nausea, vomiting, diarrhea, abdominal pain
• Headache
• Tremors, hair loss, weight gain

Serious side effects can include:

• Hepatotoxicity (liver damage), with symptoms like weakness, facial swelling, vomiting, malaise, lethargy, and anorexia
• Pancreatitis (inflammation of the pancreas), with symptoms such as abdominal pain, vomiting, nausea, and/or anorexia
• Serious allergic reactions affecting multiple organs (e.g., liver or kidney), manifesting as fever, dark urine, rash, swollen lymph glands, unusual tiredness, or yellow eyes/skin
• Hyperammonemia (high ammonia levels)
• Potential long-term side effects like osteoporosis and bone fractures, and effects on male fertility
• Suicidal thoughts (rare)

Precautions:

• Pregnancy: ENCORATE INJ is unsafe during pregnancy due to a definite risk to the developing baby, including serious birth defects (e.g., neural tube defects) and neurodevelopmental disorders. It is contraindicated in pregnant women and women of childbearing potential not using effective contraception, especially for migraine prevention.
• Liver Impairment: Not recommended for individuals with hepatic dysfunction or liver problems due to the risk of hepatotoxicity; liver function tests should be monitored.
• Kidney Impairment: Dose adjustment may be needed for patients with kidney impairment.
• Alertness: May cause dizziness, sleepiness, or decreased alertness; avoid driving or operating machinery until effects are known.
• Alcohol: Caution is advised as alcohol can increase the risk of side effects like dizziness, drowsiness, and liver strain.
• Interactions: Inform your doctor about all other medications and supplements being taken, as ENCORATE INJ can interact with other drugs. Co-administration with carbapenem agents may significantly decrease valproic acid levels.

Storage: Store in a cool and dry place, away from sunlight, typically below 30°C or between 10°C to 25°C. Keep out of reach and sight of children.

ENCORATE INJ by SUN PHARMA-SYNERGY DIV is an injectable medication containing Sodium Valproate. It is primarily used as an anticonvulsant.

Here are some frequently asked questions about ENCORATE INJ:

What is ENCORATE INJ used for?

ENCORATE INJ is primarily used to manage certain types of seizures in individuals with epilepsy, particularly when oral medications cannot be taken. It is also used to treat the manic phase of bipolar disorder and to prevent migraine headaches. In some cases, it may be used for trigeminal neuralgia.

How does ENCORATE INJ work?

ENCORATE INJ, containing Sodium Valproate, works as an anticonvulsant by stabilizing electrical activity in the brain. It increases the concentration of gamma-aminobutyric acid (GABA), a neurotransmitter that helps reduce nerve transmission and excitability in the brain. It also inhibits voltage-gated sodium and calcium channels, which contributes to its anti-seizure effects.

What is the usual dosage of ENCORATE INJ?

The dosage of ENCORATE INJ varies significantly based on the patient's age, body weight, medical condition, and response to treatment. It is typically administered as a slow intravenous injection over 3-5 minutes, followed by continuous or repeated infusion. Initial doses often range from 10 to 15 mg/kg per day and may be increased by 5 to 10 mg/kg per week, up to a maximum of 60 mg/kg per day or 2500 mg/day for adults. Your doctor will determine the appropriate dose and duration. This injection is intended for temporary use, and patients are usually switched to oral valproate therapy as soon as possible.

What are the possible side effects of ENCORATE INJ?

Common side effects can include stomach pain, diarrhea, headache, feeling tired or sleepy, weight gain, nausea, vomiting, and hair loss or thinning.

More serious side effects, though less common, require immediate medical attention. These include signs of liver problems (yellowing of skin/eyes, dark urine, severe stomach pain), pancreatitis (severe abdominal pain with nausea/vomiting), serious skin reactions (rash, blistering, peeling), confusion, unusual drowsiness, or problems with coordination (which could indicate hyperammonemic encephalopathy), low body temperature, or unusual bleeding or bruising. Long-term use can sometimes lead to bone issues like osteoporosis or affect fertility.

Is ENCORATE INJ safe during pregnancy or breastfeeding?

Pregnancy: ENCORATE INJ is generally not recommended during pregnancy, especially during the first trimester, due to a high risk of birth defects (such as neural tube defects, facial, heart, or limb problems) and neuro-developmental disorders (learning and behavioral problems) in the unborn baby. Women of childbearing potential taking this medication must use effective contraception consistently. It should only be used in pregnant women if there are no other suitable treatment options and under a strict pregnancy prevention program monitored by a specialist.

Breastfeeding: Small amounts of Sodium Valproate pass into breast milk, but it usually does not cause side effects in healthy breastfed babies. Your doctor may still recommend it if it's the only effective treatment for you. It's important to monitor the baby for any unusual sleepiness, irritability, or feeding issues.

Can ENCORATE INJ be taken with other medications?

ENCORATE INJ can interact with various other medications, potentially altering their effects or increasing the risk of side effects. For example:

• Some other anti-epileptic drugs (like phenytoin, phenobarbital, carbamazepine, primidone) can reduce the effectiveness of valproate, while valproate can increase the levels of drugs like phenobarbital and lamotrigine, leading to increased toxicity.
• Aspirin can increase valproic acid concentrations, raising the risk of toxicity.
• Certain antibiotics (e.g., carbapenems) can decrease valproate levels, making it less effective.
• Concurrent use with topiramate or acetazolamide may increase the risk of encephalopathy or hyperammonemia. Always inform your doctor or pharmacist about all other medications, supplements, and herbal products you are taking to avoid potential interactions.

What precautions should be taken while receiving ENCORATE INJ?

• Your doctor will monitor your progress closely with blood and urine tests, especially liver function tests.
• Do not drive or operate machinery until you know how the medication affects you, as it can cause dizziness and drowsiness.
• Avoid alcohol while receiving this medication, as it can worsen drowsiness.
• This medicine is not suitable for individuals with active liver disease, certain genetic disorders (like urea cycle disorder or mitochondrial disorder), or a history of severe allergic reactions to valproate.
• Do not stop receiving ENCORATE INJ abruptly without consulting your doctor, as this can lead to increased seizure frequency.
• Report any signs of serious side effects like severe stomach pain, yellow skin/eyes, or unusual bleeding to your doctor immediately.
• Weight gain is a possible side effect; monitor your weight and discuss any concerns with your doctor.

What happens if a dose of ENCORATE INJ is missed?

Since ENCORATE INJ is typically administered by a healthcare professional in a hospital or clinic setting, missed doses are generally managed by the medical staff. If you are receiving this medication and believe a dose has been missed, you should immediately inform your doctor or nurse. Missing doses can increase the risk of seizures.

How should ENCORATE INJ be stored?

ENCORATE INJ is typically stored in a clinical setting and not at home. It should be stored at a controlled room temperature, usually between 15-30°C (59-86°F). It should not be frozen and should be protected from light. As it comes in single-dose vials, any unused portion should be discarded.